Trial NCT04209621

View at ClinicalTrials.gov 
Org. Study IDs: 200016
Secondary IDs: 20-H-0016

Last trial update was posted on 2022-03-09

MeSH Interventions

Ibrutinib

MeSH Conditions

Leukemia Leukemia, Lymphocytic, Chronic, B-Cell Leukemia, Lymphoid

Other Conditions

Chronic Lymphocytic Leukemia (CLL) Small Lymphocytic Leukemia (SLL)

Stopping Reasons

Due to unexpected sudden death on study.

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID